MHC Class II Presentation of Human Acetylcholine Receptor in Myasthenia gravis : Binding of Synthetic Gamma Subunit Sequences to DR Molecules

By Yuen M.H.   Macklin K.D.   Conti-Fine B.M.  

Journal of Autoimmunity, Vol. 9, Iss. 1, 1996-01 ,pp. : 67-77

Academic Press

Access to resources Recommend Favorite

HLA Class II and class I polymorphism in venezuelan patients with myasthenia gravis

By Fernandez-Mestre M.T.   Vargas V.   Montagnani S.   Cotua M.   Ogando V.   Layrisse Z.  

Human Immunology, Vol. 65, Iss. 1, 2004-01 ,pp. : 54-59

Elsevier

Access to resources Recommend Favorite

Myocytes Respond to both Interleukin-4 and Interferon-γ: Cytokine Responsiveness with the Potential to Influence the Severity and Course of Experimental Myasthenia Gravis

By Stegall T.   Krolick K.A.  

Clinical Immunology, Vol. 94, Iss. 2, 2000-02 ,pp. : 133-139

Academic Press

Access to resources Recommend Favorite

MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?

By Jabrane-Ferrat N.  

International Immunology, Vol. 15, Iss. 4, 2003-04 ,pp. : 467-475

Oxford University Press

Access to resources Recommend Favorite

Anti-TNF-α Antibodies Suppress the Development of Experimental Autoimmune Myasthenia Gravis

By Duan R-S.   Wang H-B.   Yang J-S.   Scallon B.   Link H.   Xiao B-G.  

Journal of Autoimmunity, Vol. 19, Iss. 4, 2002-12 ,pp. : 169-174

Academic Press

Access to resources Recommend Favorite